Table 4. Main laboratory findings on admission in patients admitted to ICU due to COVID-19 and with SARS-CoV-2 as a comorbidity.
| Variables (units) | Normal range | Patients admitted due to COVID-19 | Patients with SARS-CoV-2 as comorbidity | P value |
|---|---|---|---|---|
| N (%) | – | 50 (82.0) | 11 (18.0) | – |
| Lymphocytes (%) | 20–40 | 10.8±8.6 | 19.0±11.6 | 0.028 |
| CRP (mg/dL) | <0.5 | 14.6±9.3 | 6.3±4.1 | 0.0001 |
| PCT (ng/mL) | <0.5 | 0.4 (0.2; 0.8) | 0.4 (0.1; 4.0) | 0.89 |
| IL-6 (pg/mL) | <7 | 147 (55; 355) | 224 (37; 267) | 0.80 |
| D-dimer (µg/mL) | <0.5 | 3.5±4.0 | 4.0±3.6 | 0.77 |
| hs-troponin (pg/mL) | <14 | 38.0 (20.5; 92.5) | 63.5 (25.0; 132.0) | 0.41 |
| NT-proBNP (pg/mL) | <125 | 1,681 (426; 3,965) | 3,664 (263; 7,326) | 0.58 |
| LDH (U/L) | <250 | 538 (424; 688) | 281 (199; 405) | 0.004 |
| Creatinine (mg/dL) | 0.5–0.9 | 1.7±1.9 | 1.7±0.9 | 0.98 |
Data were presented as mean ± standard deviation or median days (IQR) if not otherwise specified. ICU, intensive care unit; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus type 2; CRP, C-reactive protein; PCT, procalcitonin; IL-6, interleukin-6; hs, high sensitive; NT-proBNP, N-terminal pro-B-type natriuretic peptide; LDH, lactate dehydrogenase; IQR, interquartile range.